ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 135 filers reported holding ASCENDIS PHARMA A/S in Q2 2019. The put-call ratio across all filers is 0.27 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,296,000 | -5.0% | 23,837 | +13.6% | 0.08% | -7.0% |
| Q2 2019 | $2,416,000 | +4.8% | 20,984 | +7.1% | 0.09% | -14.0% |
| Q1 2019 | $2,306,000 | +37.8% | 19,595 | -26.7% | 0.10% | -1.0% |
| Q4 2018 | $1,674,000 | -48.3% | 26,723 | -41.5% | 0.10% | -36.5% |
| Q3 2018 | $3,240,000 | +11.1% | 45,716 | +4.3% | 0.16% | +8.2% |
| Q2 2018 | $2,916,000 | +5.8% | 43,839 | +4.0% | 0.15% | -23.0% |
| Q1 2018 | $2,756,000 | – | 42,144 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |